Tech Center 1600 • Art Units: 1655
This examiner grants 37% of resolved cases
Catheryne Chen is an examiner in Tech Center 1600 and Art Unit 1655 with 791 resolved cases. The allowance rate is 37.4%, which indicates a more challenging prosecution environment. The median days to allowance is 1551, reflecting a long and rigorous path to obtaining a patent. This 1551-day timeline requires significant persistence from applicants. The 37.4% rate suggests that many applications face multiple rounds of rejection in Art Unit 1655.
The interview lift is 18.0%. This suggests that while the 37.4% allowance rate is low, interviews can provide a meaningful boost to an application's chances. Given the 1551-day median pendency, any strategy that improves the 37.4% rate is worth considering. Practitioners in Tech Center 1600 should be prepared for a difficult and lengthy process. The 18.0% lift indicates that direct communication is a valuable tactic for overcoming hurdles.
The 791 resolved cases provide a strong statistical basis for these trends. The 37.4% allowance rate and 1551-day median to allowance are the primary factors for applicants to manage. The 18.0% interview lift offers a tactical advantage for those navigating the complexities of Art Unit 1655. Practitioners should use these figures to set realistic expectations for the 1551-day duration.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18579985 | CONSTITUENT, DERIVATIVE OR EXTRACT OF CANNABIS IN A WATER SOLUBLE MATRIX | Non-Final OA | Nicoventures Trading Limited |
| 18511413 | CHROMIUM CONTAINING COMPOSITIONS FOR IMPROVING HEALTH AND FITNESS | Final Rejection | Nutrition21, LLC |
| 18291577 | COMPOSITION, AND EXTRACT OF CHLAMYDOMONAS REINHARDTII | Final Rejection | HONDA MOTOR CO., LTD. |
| 18709931 | METHODS AND COMPOSITIONS FOR REPAIR OF TENDON-BONE INTERFACE | Non-Final OA | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH |
| 18822591 | Application of Gastrodia elata Blume derived nano-extracellular vesicles in the preparation of drugs for the prevention and/or treatment of subarachnoid hemorrhage | Non-Final OA | Zhejiang University |
| 17907645 | PREPARATION FOR USE AS ANTIOXIDANT | Non-Final OA | Evonik Operations GmbH |
| 18720453 | ANTI-STRESS COMPOSITION COMPRISING NATURAL EXTRACT MIXTURE, AND USE THEREOF | Non-Final OA | AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION |
| 17790306 | Composition Containing Paper Extracts | Non-Final OA | LG Household & Health Care Ltd. |
| 18395764 | METHODS FOR IMPROVING BONE QUALITY AND PROMOTING CARTILAGE DIFFERENTIATION BY CHRYSOPHYLLUM CAINITO EXTRACT AND MANUFACTURING METHOD THEREOF | Final Rejection | TCI CO., LTD. |
| 18615328 | STIMULATION OF ANGIOGENESIS BY FIBROBLAST DERIVED EXOSOMES | Non-Final OA | FIGENE, LLC |
| 18619519 | INFLAMMATORY CYTOKINE PRODUCTION INHIBITOR | Final Rejection | SAISEI PHARMA CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy